APA (7th ed.) Citation

A, M., L, B., L, K., DJ, K., LK, F., L, B., . . . MC, N. (2021). HLA Ligand Atlas: A benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy. Journal for immunotherapy of cancer, 9(4), . https://doi.org/10.1136/jitc-2020-002071

Chicago Style (17th ed.) Citation

A, Marcu, et al. "HLA Ligand Atlas: A Benign Reference of HLA-presented Peptides to Improve T-cell-based Cancer Immunotherapy." Journal for Immunotherapy of Cancer 9, no. 4 (2021). https://doi.org/10.1136/jitc-2020-002071.

MLA (9th ed.) Citation

A, Marcu, et al. "HLA Ligand Atlas: A Benign Reference of HLA-presented Peptides to Improve T-cell-based Cancer Immunotherapy." Journal for Immunotherapy of Cancer, vol. 9, no. 4, 2021, https://doi.org/10.1136/jitc-2020-002071.